Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

ClinicalTrials.gov ID: NCT07484217

Public ClinicalTrials.gov record NCT07484217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Study of Solriamfetol in Subjects With Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Study identification

NCT ID: NCT07484217
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Axsome Therapeutics, Inc.; Industry
Enrollment: 508 participants

Conditions and interventions

Conditions

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Interventions

Placebo Drug
Solriamfetol 150 MG Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 22, 2026
Primary completion: Nov 30, 2028
Completion: Nov 30, 2028
Last update posted: Mar 19, 2026

2026 – 2028

United States locations

U.S. sites: 13
U.S. states: 8
U.S. cities: 13

Facility	City	State	ZIP	Site status
Clinical Research Site	Chino	California	91710	Recruiting
Clinical Research Site	Redlands	California	92374	Recruiting
Clinical Research Site	Walnut Creek	California	94596	Recruiting
Clinical Research Site	Jacksonville	Florida	32256	Recruiting
Clinical Research Site	Miami	Florida	33176	Recruiting
Clinical Research Site	Cherry Hill	New Jersey	08002	Recruiting
Clinical Research Site	Toms River	New Jersey	08755	Recruiting
Clinical Research Site	Brooklyn	New York	11235	Recruiting
Clinical Research Site	The Bronx	New York	10464	Recruiting
Clinical Research Site	Cincinnati	Ohio	45215	Recruiting
Clinical Research Site	Portland	Oregon	97210	Recruiting
Clinical Research Site	Memphis	Tennessee	38119	Recruiting
Clinical Research Site	Dallas	Texas	75243	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07484217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 19, 2026 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07484217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →